These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 34694467)

  • 21. Mechanisms of coronavirus infectious disease 2019-related neurologic diseases.
    Klein RS
    Curr Opin Neurol; 2022 Jun; 35(3):392-398. PubMed ID: 35283461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic.
    Kaushik P; Kaushik M; Parveen S; Tabassum H; Parvez S
    Mol Neurobiol; 2020 Dec; 57(12):4921-4928. PubMed ID: 32813238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies.
    Chong ZZ; Souayah N
    Curr Med Chem; 2022; 29(12):2051-2074. PubMed ID: 33970839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19.
    Baig AM
    ACS Chem Neurosci; 2020 Aug; 11(16):2416-2421. PubMed ID: 32600045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible routes of SARS-CoV-2 invasion in brain: In context of neurological symptoms in COVID-19 patients.
    Kumar A; Pareek V; Prasoon P; Faiq MA; Kumar P; Kumari C; Narayan RK
    J Neurosci Res; 2020 Dec; 98(12):2376-2383. PubMed ID: 32869376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurological associations of COVID-19.
    Ellul MA; Benjamin L; Singh B; Lant S; Michael BD; Easton A; Kneen R; Defres S; Sejvar J; Solomon T
    Lancet Neurol; 2020 Sep; 19(9):767-783. PubMed ID: 32622375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 may trigger inflammasome and pyroptosis in the central nervous system: a mechanistic view of neurotropism.
    Sepehrinezhad A; Gorji A; Sahab Negah S
    Inflammopharmacology; 2021 Aug; 29(4):1049-1059. PubMed ID: 34241783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurotropism and Neuropsychiatric Symptomsi in Patients with COVID-19.
    Moretti P; Brufani F; Pierotti V; Pomili G; Di Buò A; Giulietti C; Masini F; Tanku V; Bachetti MC; Menculini G; Tortorella A
    Psychiatr Danub; 2021 Dec; 33(Suppl 11):10-13. PubMed ID: 34862882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging neurotropic features of SARS-CoV-2.
    Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG
    J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurological consequences of COVID-19.
    Brola W; Wilski M
    Pharmacol Rep; 2022 Dec; 74(6):1208-1222. PubMed ID: 36180640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19: A Global Threat to the Nervous System.
    Koralnik IJ; Tyler KL
    Ann Neurol; 2020 Jul; 88(1):1-11. PubMed ID: 32506549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central Nervous System Targets and Routes for SARS-CoV-2: Current Views and New Hypotheses.
    Barrantes FJ
    ACS Chem Neurosci; 2020 Sep; 11(18):2793-2803. PubMed ID: 32845609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurological manifestations of COVID-19: A brief review.
    Sachdev K; Agrawal S; Ish P; Gupta N; Raheja K
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):41-47. PubMed ID: 32859864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 neurotropism and other possible causes of olfactory disorders in COVID-19.
    Sowa P; Dadok A; Adamczyk-Sowa M
    Neurol Neurochir Pol; 2023; 57(1):36-42. PubMed ID: 36805466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Mechanisms of SARS-CoV-2/COVID-19 Pathogenicity on the Central Nervous System: Bridging Experimental Probes to Clinical Evidence and Therapeutic Interventions.
    Groppa SA; Ciolac D; Duarte C; Garcia C; Gasnaș D; Leahu P; Efremova D; Gasnaș A; Bălănuță T; Mîrzac D; Movila A
    Adv Exp Med Biol; 2022; 1376():1-27. PubMed ID: 34735712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human brain organoids to explore SARS-CoV-2-induced effects on the central nervous system.
    Ostermann PN; Schaal H
    Rev Med Virol; 2023 Mar; 33(2):e2430. PubMed ID: 36790825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
    Zhou Z; Kang H; Li S; Zhao X
    J Neurol; 2020 Aug; 267(8):2179-2184. PubMed ID: 32458193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Post COVID-19 disorders: is the epidemic of parkinsonism threatening the world?].
    Damulin IV; Strutzenko AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(9):22-28. PubMed ID: 36168684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-Cov-2 infection and neuropathological findings: a report of 18 cases and review of the literature.
    Lebrun L; Absil L; Remmelink M; De Mendonça R; D'Haene N; Gaspard N; Rusu S; Racu ML; Collin A; Allard J; Zindy E; Schiavo AA; De Clercq S; De Witte O; Decaestecker C; Lopes MB; Salmon I
    Acta Neuropathol Commun; 2023 May; 11(1):78. PubMed ID: 37165453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 and the nervous system.
    Berger JR
    J Neurovirol; 2020 Apr; 26(2):143-148. PubMed ID: 32447630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.